A first-in-human phase I dose-escalation trial of the B7-H6/CD3 T-cell engager BI 765049 ± ezabenlimab (BI 754091) in patients with advanced solid tumors expressing B7-H6

被引：0
|
作者：
Falchook, Gerald Steven
Patel, Manish R.
Ulahannan, Susanna Varkey
Maier, Daniela
Hipp, Susanne
Azuma, Hisaya
Spigel, David R.
机构：
[1] HealthONE, Sarah Cannon Res Inst, Denver, CO USA
[2] Florida Canc Specialists & Res Inst, Sarasota, FL USA
[3] Univ Oklahoma Hlth Sci Ctr, Sarah Cannon Res Inst, Oklahoma City, OK USA
[4] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
[5] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[6] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[7] Sarah Cannon Res Inst, Tennessee Oncol Nashville, PLLC, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS3175
引用
收藏
页数：1
相关论文
共 42 条
  • [41] Alnuctamab (ALNUC; BMS-986349; CC-93269), a 2+1 B- Cell Maturation Antigen (BCMA) x CD3 T-Cell Engager (TCE), Administered Subcutaneously (SC) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from a Phase 1 First-in-Human Clinical Study
    Bar, Noffar
    Victoria Mateos, Maria
    Ribas, Paz
    Hansson, Markus
    Paris, Laura
    Hofmeister, Craig C.
    Rodriguez Otero, Paula
    Aranzazu Bermudez, Maria
    Martin, Thomas
    Santoro, Armando
    Yee, Andrew J.
    Creignou, Maria
    Encinas Rodriguez, Cristina
    Cerchione, Claudio
    De La Rubia, Javier
    Oriol, Albert
    Waibel, Heidi
    Besemer, Britta
    Thompson, Ethan
    Kiesel, Brian
    Chen, Jinjie
    Chung, Alexander
    Boss, Isaac W.
    Gaudy, Allison
    Li, Shaoyi
    Hsu, Kevin
    Godwin, Colin
    Burgess, Michael R.
    San-Miguel, Jesus
    Costa, Luciano
    BLOOD, 2023, 142
  • [42] DAREON-8: A phase I, open-label, dose escalation/expansion trial of the DLL3-targeting T-cell engager, BI 764532, combined with first-line (1L) standard of care (platinum, etoposide, and anti-PD-L1 antibody) in patients (pts) with extensive-stage small cell lung carcinoma (ES-SCLC)
    Peters, Solange
    Champiat, Stephane
    Yoshida, Tatsuya
    Dorleacq, Nicolas
    Ma, Yiyuan
    Geng, Lijiang
    Leal, Ticiana
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345